Copyright
©The Author(s) 2024.
World J Psychiatry. Mar 19, 2024; 14(3): 445-455
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.445
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.445
Figure 5 KAT7 epigenetically induces dual-specificity tyrosine phosphorylation-regulated kinase-1A expression.
A: RNA level of KAT7 in neurons after transfection of siKAT7-1, siKAT7-2, or siKAT7-3 was measured using qPCR; B: RNA level of dual-specificity tyrosine phosphorylation-regulated kinase-1A (DYRK1A) in neurons after siKAT7-3 transfection was measured using qPCR; C: Chromatin immunoprecipitation assay to measure enrichment of H3K14ac on DYRK1A gene; D: RNA level of HMGN1 in neurons after transfection of siHMGN1-1, siHMGN1-2, or siHMGN1-3 was measured using qPCR; E: RNA level of DYRK1A in neurons after transfection of siHMGN1-3 was measured using qPCR; F and G: RNA and protein levels of DYRK1A in neurons after siKAT7-3 transfection with or without KAT7 overexpression vectors was measured using qPCR. bP < 0.01. DYRK1A: Dual-specificity tyrosine phosphorylation-regulated kinase-1A.
- Citation: Lu QS, Ma L, Jiang WJ, Wang XB, Lu M. KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer’s disease. World J Psychiatry 2024; 14(3): 445-455
- URL: https://www.wjgnet.com/2220-3206/full/v14/i3/445.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i3.445